Pure Global

Spinal nalbuphine in anorectal surgery - Trial PACTR201612001903142

Access comprehensive clinical trial information for PACTR201612001903142 through Pure Global AI's free database. This Not Applicable trial is sponsored by Mansoura University hospitals and is currently Recruiting. The study focuses on Surgery; Other.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
PACTR201612001903142
Not Applicable
Recruiting
other
Trial Details
Pan Africa Clinical Trials Registry โ€ข PACTR201612001903142
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Spinal nalbuphine in anorectal surgery
Optimal dose intrathecal nalbuphine may improve markedly the duration analgesia with low side effect profile during anorectal surgery

Study Focus

Surgery; Other

other

Sponsor & Location

Mansoura University hospitals

Egypt

Timeline & Enrollment

Not Applicable

Mar 01, 2016

Nov 30, 2016

Summary

There is no doubt that intrathecal opioids have been used for subarachnoid block with or without local anesthetic to allow complete analgesia during surgical procedures. However their use is limited for fear of their side effects specially respiratory depression . Morphine is the standard opioid medication used for intra and postoperative analgesia . But owing to its associated adverse effects including (respiratory depression , nausea , vomiting constipation , pruritis and urine retention) its use is limited . (1)Various agents have been searched to replace morphine . Optimization of the dose of spinal narcotics is vital to avoid unpleasant side effects. Nalbuphine which is a mixed agonist antagonist ' being kappa agonist and mu antagonist can be preferred due to less respiratory depression and vomiting than morphine . Also It can mimic morphine in its analgesic duration if used with optimal dose .Nalbuphine,on the other hand, being mu antagonist and kappa agonist ,has a ceiling effect in its respiratory depression [2,3];hence it is considered to be safer than morphine. Many studies have reported that the incidence of adverse effects like pruritus and PONV is lower with nalbuphine in comparison with morphine [4, 5]. One study concluded that the optimal dose of nalbuphie is 0.8 mg in surgery while another one concluded that it is 1.6 mg in lower limb surgery . We hypotheses that higher doses of nalbuphine can improve markedly duration of analgesia with insignificant side effect profile.

ICD-10 Classifications

Other surgical procedures
Other medical procedures
Other reconstructive surgery
During other surgical and medical care
During other surgical and medical care

Data Source

Pan Africa Clinical Trials Registry

PACTR201612001903142

Non-Device Trial